BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16651818)

  • 1. Deterioration in acute ischemic stroke as the target for neuroprotection.
    Serena J; Rodríguez-Yáñez M; Castellanos M
    Cerebrovasc Dis; 2006; 21 Suppl 2():80-8. PubMed ID: 16651818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets of cytoprotection in acute ischemic stroke: present and future.
    Lizasoain I; Cárdenas A; Hurtado O; Romera C; Mallolas J; Lorenzo P; Castillo J; Moro MA
    Cerebrovasc Dis; 2006; 21 Suppl 2():1-8. PubMed ID: 16651809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids modulate post-ischemic progression in a rat model of stroke.
    Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ
    Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression in cerebral ischemia: a new approach for neuroprotection.
    Millán M; Arenillas J
    Cerebrovasc Dis; 2006; 21 Suppl 2():30-7. PubMed ID: 16651812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke?
    Gibson CL; Coomber B; Rathbone J
    Neuroscientist; 2009 Aug; 15(4):324-32. PubMed ID: 19359672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.
    Saver JL
    Pharmacotherapy; 2010 Jul; 30(7 Pt 2):62S-9S. PubMed ID: 20575624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular protection in brain ischemia.
    Rodríguez-Yáñez M; Castellanos M; Blanco M; Mosquera E; Castillo J
    Cerebrovasc Dis; 2006; 21 Suppl 2():21-9. PubMed ID: 16651811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copolymer-1 (Cop-1) improves neurological recovery after middle cerebral artery occlusion in rats.
    Ibarra A; Avendaño H; Cruz Y
    Neurosci Lett; 2007 Sep; 425(2):110-3. PubMed ID: 17868996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside.
    Ntaios G; Savopoulos C; Chatzinikolaou A; Hatzitolios AI
    Acta Neurol Scand; 2008 Dec; 118(6):362-6. PubMed ID: 18513348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Past, present and future of neuroprotection].
    Mracek J
    Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target brain: neuroprotection and neurorestoration in ischemic stroke.
    Saver JL
    Rev Neurol Dis; 2010; 7 Suppl 1():S14-21. PubMed ID: 20410866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic preconditioning: a novel target for neuroprotective therapy.
    Blanco M; Lizasoain I; Sobrino T; Vivancos J; Castillo J
    Cerebrovasc Dis; 2006; 21 Suppl 2():38-47. PubMed ID: 16651813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action.
    Chen B; Liao WQ; Xu N; Xu H; Wen JY; Yu CA; Liu XY; Li CL; Zhao SM; Campbell W
    Brain Res; 2009 Jun; 1273():129-37. PubMed ID: 19362080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving paradigms for neuroprotection: molecular identification of ischemic penumbra.
    Castellanos M; Sobrino T; Castillo J
    Cerebrovasc Dis; 2006; 21 Suppl 2():71-9. PubMed ID: 16651817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats.
    Michalski D; Küppers-Tiedt L; Weise C; Laignel F; Härtig W; Raviolo M; Schneider D; Hobohm C
    Brain Res; 2009 Dec; 1303():161-8. PubMed ID: 19766603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection in acute ischaemic stroke. II: Clinical potential.
    Davis M; Barer D
    Vasc Med; 1999; 4(3):149-63. PubMed ID: 10512595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection from the collateral perspective.
    Liebeskind DS
    IDrugs; 2005 Mar; 8(3):222-8. PubMed ID: 15772894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
    Candelario-Jalil E
    Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice.
    Wang HW; Liou KT; Wang YH; Lu CK; Lin YL; Lee IJ; Huang ST; Tsai YH; Cheng YC; Lin HJ; Shen YC
    J Ethnopharmacol; 2011 Oct; 138(1):22-33. PubMed ID: 21784143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
    Köhrmann M; Schellinger PD; Schwab S
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.